greeksoup/ stock research
Stock research / United States / BMY / Planned sales

Bristol-Myers Squibb Co. planned insider sales

In the last twelve months insiders at Bristol-Myers Squibb Co. filed 4 Form 144 notices of planned sales, 40,549 shares worth $2.5 million at the time of filing, from 4 sellers. The latest, filed 6 November 2026: Julia A Haller Gottsch (director), 3,800 shares worth $250,000, planned for around 5 November 2026 through Merrill Lynch.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
6 November 2026Julia A Haller GottschDirector3,800$250,0005 November 20263,800 shares from 5 November 2026Merrill Lynchstock bonusForm 144
9 September 2026Massacesi CristianOfficer6,249$403,4989 September 20266,249 shares from 9 September 2026Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
25 August 2026Holzer Phil MOfficer500$33,75025 August 2026500 shares from 25 August 2026Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
1 April 2026Elkins David VOfficer30,000$1.9 million1 April 202630,000 shares from 1 April 2026Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?